1. New Biogen data showed no major safety issues for its Alzheimer's drug — Lilly puts its oncology future in Lox’s hands — Sage Therapeutics depression drug fails phase 3 trial — See more on our front page news

    TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

Poly Pharmaceuticals

Anonymous board for Poly Pharmaceuticals


Sort By:
Title
Replies Views
Last Message ↓
  1. Anonymous
    Replies:
    8
    Views:
    9,674
  2. Anonymous
    Replies:
    4
    Views:
    6,237
  3. Anonymous
    Replies:
    2
    Views:
    4,089
  4. Anonymous
    Replies:
    2
    Views:
    4,255
  5. Anonymous
    Replies:
    1
    Views:
    3,316
  6. Anonymous
    Replies:
    2
    Views:
    2,998
  7. Anonymous
    Replies:
    4
    Views:
    6,988
  8. Anonymous
    Replies:
    14
    Views:
    12,278
  9. Anonymous
    Replies:
    4
    Views:
    6,257
  10. Anonymous
    Replies:
    0
    Views:
    3,353
  11. Anonymous
    Replies:
    2
    Views:
    5,737

Thread Display Options

Loading...